U.S., March 14 -- ClinicalTrials.gov registry received information related to the study (NCT06873633) titled 'Safety, Pharmacokinetics, and Antiviral Activity of Remdesivir in Hospitalized Children with RSV' on March 03.
Brief Summary: THAI-CARES RSV Study is a Phase II, open-label, multicenter, randomized controlled trial with a two-arm, parallel-group design. The study aims to assess the safety, efficacy, and acceptability of a five-day course of Remdesivir in children under two years of age who are hospitalized with confirmed respiratory syncytial virus (RSV) infection, as determined by either a rapid antigen test or RT-PCR. The primary objectives include evaluating the treatment's safety profile, its ability to significantly reduce RSV...